Dust Mite Allergy clinical trials

The registry lists 45 studies for Dust Mite Allergy across more than 10 countries. 6 are recruiting or about to start. 31 of them are mainly about Dust Mite Allergy (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-17.

Get an email when these change. Save the Dust Mite Allergy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 29
Status unknown: 4
Not yet recruiting: 3
Recruiting: 3
Terminated: 2
Withdrawn: 2

Phase

Phase 2: 12
Phase 3: 11
Phase 1: 5
Phase 4: 2

Where

Germany: 15
Spain: 7
France: 7
United States: 4
Argentina: 2
Poland: 2

Who runs them

Inmunotek S.L. (5) · Johann Wolfgang Goethe University Hospital (3) · Stallergenes Greer (3) · Universitaire Ziekenhuizen KU Leuven (2) · Cytos Biotechnology AG (2) · University of North Carolina, Chapel Hill (2) · Circassia Limited (2) · Ecarf Institute GmbH (2)

What is being tested here

Drugs under test in Dust Mite Allergy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
MM09	1	2	2
CYT005	0	0	2
Dupilumab	0	0	1
Gamma-Tocopherol	0	0	1
Fish Oils	0	1	1
Histamine	0	0	1
Nigella sativa oil	0	0	1
Azelastine	0	0	1
Fluticasone	0	0	1

Coming up

5phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Nov 2026Dupilumab Effects Against Aeroallergen Challenge · The University of Texas Health Science Center at San Antonio
May 2027Identification of B Regulatory Cells by Flow Cytometry · Hull University Teaching Hospitals NHS Trust

Who these studies take

Of the 3 Dust Mite Allergy studies recruiting now, 1 (33%) set no upper age limit and 2 (67%) stop at 75 or younger. 2 (67%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	0 (0%)	0 (0%)
18	3 (100%)	3 (100%)
30	3 (100%)	3 (100%)
40	3 (100%)	3 (100%)
50	3 (100%)	3 (100%)
65	3 (100%)	3 (100%)
75	1 (33%)	1 (33%)
85	1 (33%)	1 (33%)

Across all 45 studies, recruiting or not: 89% stop at 75 or younger and 89% at 65; 29% take children; 0% are for women only and 0% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 45 of 45. search them.